Pediatrix Medical EBITDA Margin 2010-2024 | MD
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Pediatrix Medical (MD) over the last 10 years. The current EBITDA margin for Pediatrix Medical as of June 30, 2024 is .
| Pediatrix Medical EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2024-06-30 | $2.00B | $-0.02B | -1.00% |
| 2024-03-31 | $2.00B | $0.03B | 1.60% |
| 2023-12-31 | $2.00B | $0.05B | 2.26% |
| 2023-09-30 | $2.01B | $0.19B | 9.59% |
| 2023-06-30 | $2.00B | $0.20B | 10.02% |
| 2023-03-31 | $1.98B | $0.20B | 10.15% |
| 2022-12-31 | $1.97B | $0.21B | 10.65% |
| 2022-09-30 | $1.96B | $0.24B | 12.31% |
| 2022-06-30 | $1.96B | $0.25B | 12.91% |
| 2022-03-31 | $1.95B | $0.25B | 12.99% |
| 2021-12-31 | $1.91B | $0.24B | 12.55% |
| 2021-09-30 | $1.83B | $0.21B | 11.26% |
| 2021-06-30 | $1.80B | $0.17B | 9.23% |
| 2021-03-31 | $1.74B | $0.15B | 8.62% |
| 2020-12-31 | $1.73B | $0.13B | 7.73% |
| 2020-09-30 | $1.78B | $0.14B | 7.88% |
| 2020-06-30 | $1.77B | $0.15B | 8.59% |
| 2020-03-31 | $1.92B | $0.18B | 9.24% |
| 2019-12-31 | $2.33B | $0.26B | 11.09% |
| 2019-09-30 | $1.02B | $0.09B | 9.18% |
| 2019-06-30 | $1.42B | $0.18B | 12.76% |
| 2019-03-31 | $1.72B | $0.26B | 14.92% |
| 2018-12-31 | $1.72B | $0.28B | 16.13% |
| 2018-09-30 | $3.27B | $0.50B | 15.18% |
| 2018-06-30 | $3.29B | $0.52B | 15.85% |
| 2018-03-31 | $3.27B | $0.53B | 16.11% |
| 2017-12-31 | $3.25B | $0.54B | 16.56% |
| 2017-09-30 | $3.38B | $0.60B | 17.88% |
| 2017-06-30 | $3.34B | $0.63B | 18.96% |
| 2017-03-31 | $3.27B | $0.65B | 19.99% |
| 2016-12-31 | $3.18B | $0.67B | 20.89% |
| 2016-09-30 | $3.10B | $0.67B | 21.49% |
| 2016-06-30 | $2.99B | $0.65B | 21.81% |
| 2016-03-31 | $2.89B | $0.64B | 22.11% |
| 2015-12-31 | $2.78B | $0.62B | 22.45% |
| 2015-09-30 | $2.69B | $0.61B | 22.72% |
| 2015-06-30 | $2.59B | $0.59B | 22.78% |
| 2015-03-31 | $2.51B | $0.57B | 22.84% |
| 2014-12-31 | $2.44B | $0.56B | 22.91% |
| 2014-09-30 | $2.36B | $0.54B | 22.79% |
| 2014-06-30 | $2.28B | $0.52B | 22.85% |
| 2014-03-31 | $2.22B | $0.51B | 22.78% |
| 2013-12-31 | $2.15B | $0.49B | 22.84% |
| 2013-09-30 | $2.06B | $0.47B | 22.79% |
| 2013-06-30 | $1.98B | $0.45B | 22.77% |
| 2013-03-31 | $1.90B | $0.43B | 22.88% |
| 2012-12-31 | $1.82B | $0.42B | 23.12% |
| 2012-09-30 | $1.75B | $0.41B | 23.30% |
| 2012-06-30 | $1.69B | $0.39B | 23.37% |
| 2012-03-31 | $1.63B | $0.39B | 23.70% |
| 2011-12-31 | $1.59B | $0.38B | 23.99% |
| 2011-09-30 | $1.55B | $0.37B | 24.11% |
| 2011-06-30 | $1.49B | $0.36B | 24.16% |
| 2011-03-31 | $1.45B | $0.35B | 24.07% |
| 2010-12-31 | $1.40B | $0.34B | 23.91% |
| 2010-09-30 | $1.37B | $0.33B | 23.94% |
| 2010-06-30 | $1.35B | $0.32B | 23.85% |
| 2010-03-31 | $1.32B | $0.31B | 23.77% |
| 2009-12-31 | $1.29B | $0.31B | 23.76% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.967B | $1.995B |
| Pediatrix Medical Group Inc. is a national medical group comprised of physician services practicing under the Pediatrix(R) brand. It provides services to women, babies and children across the continuum of care, both in hospital settings and office-based practices. Pediatrix Medical Group Inc., formerly known as Mednax Inc., is based in FORT LAUDERDALE, Fla. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $121.497B | 14.81 |
| Cencora (COR) | United States | $44.320B | 16.94 |
| ICON (ICLR) | Ireland | $23.561B | 21.17 |
| DiDi Global (DIDIY) | China | $23.282B | 0.00 |
| Avantor (AVTR) | United States | $17.560B | 26.63 |
| Natera (NTRA) | United States | $15.549B | 0.00 |
| Revvity (RVTY) | United States | $15.548B | 27.23 |
| Viatris (VTRS) | United States | $13.785B | 4.20 |
| CochLear (CHEOY) | Australia | $12.759B | 0.00 |
| Solventum (SOLV) | United States | $11.670B | 0.00 |
| Medpace Holdings (MEDP) | United States | $10.275B | 31.18 |
| Charles River Laboratories (CRL) | United States | $10.239B | 19.35 |
| Sonic Healthcare (SKHHY) | Australia | $9.066B | 0.00 |
| Doximity (DOCS) | United States | $7.965B | 50.47 |
| HealthEquity (HQY) | United States | $6.980B | 37.88 |
| Bausch + Lomb (BLCO) | Canada | $6.671B | 28.71 |
| PACS (PACS) | United States | $6.029B | 0.00 |
| Organon (OGN) | United States | $4.938B | 5.02 |
| Life Times (LTH) | United States | $4.827B | 40.35 |
| Sotera Health (SHC) | United States | $4.747B | 23.94 |
| Surgery Partners (SGRY) | United States | $4.058B | 44.96 |
| Concentras Parent (CON) | United States | $2.838B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.613B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $2.599B | 97.86 |
| BrightSpring Health Services (BTSG) | United States | $2.570B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.194B | 0.00 |
| Premier (PINC) | United States | $2.003B | 9.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.961B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $1.618B | 8.12 |
| CareDx (CDNA) | United States | $1.566B | 0.00 |
| Agilon Health (AGL) | United States | $1.539B | 0.00 |
| Progyny (PGNY) | United States | $1.517B | 26.67 |
| Teladoc Health (TDOC) | United States | $1.449B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.314B | 0.00 | |
| GeneDx Holdings (WGS) | United States | $1.153B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $1.123B | 29.39 |
| Embecta (EMBC) | United States | $0.817B | 5.45 |
| InnovAge Holding (INNV) | United States | $0.812B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.531B | 0.00 |
| Sharecare (SHCR) | United States | $0.524B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.466B | 0.00 |
| Enhabit (EHAB) | United States | $0.399B | 34.48 |
| Sonida Senior Living (SNDA) | United States | $0.378B | 0.00 |
| DocGo (DCGO) | United States | $0.346B | 13.00 |
| Sera Prognostics (SERA) | United States | $0.256B | 0.00 |
| Biodesix (BDSX) | United States | $0.248B | 0.00 |
| LifeMD (LFMD) | United States | $0.224B | 0.00 |
| ModivCare (MODV) | United States | $0.200B | 6.34 |
| Ascend Wellness Holdings (AAWH) | United States | $0.181B | 0.00 |
| Beauty Health (SKIN) | United States | $0.171B | 0.00 |
| MultiPlan (MPLN) | United States | $0.118B | 0.00 |
| Nutex Health (NUTX) | United States | $0.099B | 0.00 |
| So-Young (SY) | China | $0.093B | 22.49 |
| Harvard Apparatus Regenerative Technology (HRGN) | United States | $0.087B | 0.00 |
| SBC Medicals (SBC) | United States | $0.050B | 0.00 |
| NeueHealth (NEUE) | United States | $0.042B | 1.69 |
| Co-Diagnostics (CODX) | United States | $0.039B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.039B | 0.00 |
| OncoCyte (OCX) | United States | $0.039B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.032B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.031B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.029B | 0.00 |
| Oncology Institute (TOI) | United States | $0.023B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.018B | 0.00 |
| XWELL (XWEL) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.008B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| KindlyMD (KDLY) | $0.007B | 0.00 | |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.001B | 0.00 |